GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evoke Pharma Inc (STU:EV00) » Definitions » Cash Flow for Lease Financing

Evoke Pharma (STU:EV00) Cash Flow for Lease Financing : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Evoke Pharma Cash Flow for Lease Financing?

Evoke Pharma's Cash Flow for Lease Financing for the three months ended in Dec. 2023 was €0.00 Mil. Evoke Pharma's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Sep. 2023 ), Evoke Pharma's Cash Flow for Lease Financing remained the same in Dec. 2023 (€0.00 Mil).

Evoke Pharma Cash Flow for Lease Financing Historical Data

The historical data trend for Evoke Pharma's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evoke Pharma Cash Flow for Lease Financing Chart

Evoke Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Evoke Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Evoke Pharma Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evoke Pharma Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Evoke Pharma's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Evoke Pharma (STU:EV00) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evoke Pharma Inc (STU:EV00) » Definitions » Cash Flow for Lease Financing
Comparable Companies
UPC OWPC INQD PRFX AGRX JUVAF CLVR STEK AVRW KOAN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
EVOK:USA
Address
420 Stevens Avenue, Suite 370, Solana Beach, CA, USA, 92075
Website
https://www.evokepharma.com
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Evoke Pharma (STU:EV00) Headlines

No Headlines